Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP929898.RABiFCHmDnNqw0IzIDBJyUMmhm3gtf-rXrT-oxtfdz7bU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP929898.RABiFCHmDnNqw0IzIDBJyUMmhm3gtf-rXrT-oxtfdz7bU130_assertion type Assertion NP929898.RABiFCHmDnNqw0IzIDBJyUMmhm3gtf-rXrT-oxtfdz7bU130_head.
- NP929898.RABiFCHmDnNqw0IzIDBJyUMmhm3gtf-rXrT-oxtfdz7bU130_assertion wasGeneratedBy ECO_0000203 NP929898.RABiFCHmDnNqw0IzIDBJyUMmhm3gtf-rXrT-oxtfdz7bU130_provenance.
- NP929898.RABiFCHmDnNqw0IzIDBJyUMmhm3gtf-rXrT-oxtfdz7bU130_assertion wasDerivedFrom befree-2016 NP929898.RABiFCHmDnNqw0IzIDBJyUMmhm3gtf-rXrT-oxtfdz7bU130_provenance.
- NP929898.RABiFCHmDnNqw0IzIDBJyUMmhm3gtf-rXrT-oxtfdz7bU130_assertion SIO_000772 21986528 NP929898.RABiFCHmDnNqw0IzIDBJyUMmhm3gtf-rXrT-oxtfdz7bU130_provenance.
- NP929898.RABiFCHmDnNqw0IzIDBJyUMmhm3gtf-rXrT-oxtfdz7bU130_assertion evidence source_evidence_literature NP929898.RABiFCHmDnNqw0IzIDBJyUMmhm3gtf-rXrT-oxtfdz7bU130_provenance.
- NP929898.RABiFCHmDnNqw0IzIDBJyUMmhm3gtf-rXrT-oxtfdz7bU130_assertion description "[PLCγ is required for RhoGDI2-mediated cisplatin resistance in gastric cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP929898.RABiFCHmDnNqw0IzIDBJyUMmhm3gtf-rXrT-oxtfdz7bU130_provenance.